NICE says drug for metastatic breast cancer is unaffordable for NHS.
BMJ.
Zosia
Z
Kmietowicz
D026683:Advisory Committees; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics*; D000970:Antineoplastic Agents / Q000191:economics*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D005260:Female; D006801:Humans; D013222:State Medicine; D000068878:Trastuzumab; D006113:United Kingdom
D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab